Are COPD Prescription Patterns Aligned with Guidelines? Evidence from a Canadian Population-Based Study

References

• Qureshi H, Sharafkhaneh A, Hanania NA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Advan Chronic Dis. 2014;5(5):212–227. doi:10.1177/2040622314532862
   PubMedGoogle Scholar
• Collaborators CRD. GBD 2015 Chronic Respiratory Disease Collaborators Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706.
   PubMed Web of Science ®Google Scholar
• WHO. Burden of COPD. Avialable from: https://www.who.int/respiratory/copd/burden/en/. Accessed May 14, 2020.
   Google Scholar
• Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(6):596–601. doi:10.1164/rccm.201211-2044OC
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Can J Respir Crit Care Sleep Med. 2019;3(4):210–232. doi:10.1080/24745332.2019.1668652
   Web of Science ®Google Scholar
• Pharmacologic Management of Chronic Obstructive Pulmonary DiseaseAugust. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020. https://www.atsjournals.org/doi/10.1164/rccm.202003-0625ST.
   Web of Science ®Google Scholar
• Cantrell CR, Priest JL, Cook CL, Fincham J, Burch SP. Adherence to treatment guidelines and therapeutic regimens: a US claims-based benchmark of a commercial population. Popul Health Manage. 2011;14(1):33–41. doi:10.1089/pop.2010.0018
   PubMed Web of Science ®Google Scholar
• Services M of C. Population Estimates - Province of British Columbia. Available from: https://www2.gov.bc.ca/gov/content/data/statistics/people-population-community/population/population-estimates. Accessed July 22, 2020.
   Google Scholar
• Williams JI, Young W. Inventory of Studies on the Accuracy of Canadian Health Administrative Databases. ICES; 1996.
   Google Scholar
• British Columbia Ministry of Health [creator] (2013): Consolidation File (MSP Registration & Premium Billing). Population Data BC [publisher]. Data Extract. MOH. Available from: http://www.popdata.bc.ca/data. Accessed March 15, 2021.
   Google Scholar
• Canadian Institute for Health Information [creator].Discharge Abstract Database (Hospital Separations). Population Data BC [Publisher]. Data Extract. MOH; 2014. Available from: http://www.popdata.bc.ca/data.
   Google Scholar
• British Columbia. Ministry of Health Services MSP Fee-For-Service Payment Analysis | BC Government Publication | Legislative Library | Legislative Assembly of British Columbia. Available from: http://www.llbc.leg.bc.ca/public/pubdocs/bcdocs/350351/index.htm>. Accessed March 15, 2021.
   Google Scholar
• BC Ministry of Health [creator] (2014): PharmaNet. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2013). Available from: http://www.popdata.bc.ca/data. Accessed March 15, 2021.
   Google Scholar
• Kendzerska T, Leung R, Sandoz J, Gershon AS. C110 OSA OVERLAPS: ASTHMA, COPD, OBESITY HYPOVENTILATION SYNDROME, AND LUNG CANCER: modifiable effect of co-existence of chronic obstructive pulmonary disease and obstructive sleep apnea: evidence from clinical and health administrative data. Am J Respir Crit Care Med. 2017;195.
   Web of Science ®Google Scholar
• Tavakoli H, Johnson KM, FitzGerald JM, et al. Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada. Int J Chronic Obstruct Pulmonary Dis. 2019;14:2003. doi:10.2147/COPD.S210897
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD. 2009;6(5):388–394. doi:10.1080/15412550903140865
   PubMedGoogle Scholar
• Falk J, Dik N, Bugden S. An evaluation of early medication use for COPD: a population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:3101–3108. doi:10.2147/COPD.S123643
   PubMed Web of Science ®Google Scholar
• Fabricius P, Løkke A, Marott JL, Vestbo J, Lange P. Prevalence of COPD in Copenhagen. Respiratory Medicine. 2011;105(3):410–417. doi:10.1016/j.rmed.2010.09.019
   PubMed Web of Science ®Google Scholar
• Tavakoli H, Chen W, Sin DD, FitzGerald JM, Sadatsafavi M. Predicting Severe COPD Exacerbations: developing a Population Surveillance Approach with Administrative Data. Annals ATS. 2020;17(9):1069–1076. doi:10.1513/AnnalsATS.202001-070OC
   Web of Science ®Google Scholar
• Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying patients with physician-diagnosed asthma in health administrative databases. Can Respir J. doi:10.1155/2009/963098
   Web of Science ®Google Scholar
• Wijayaratne K, Wilson J, Sivakumaran P, Sriram KB. Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Thorac Med. 2013;8(4):197–203. doi:10.4103/1817-1737.118499
   PubMed Web of Science ®Google Scholar
• White P, Thornton H, Pinnock H, Georgopoulou S, Booth HP. Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: cross-Sectional Observational Study. PLoS One. 2013;8(10):e75221. doi:10.1371/journal.pone.0075221
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the case study. Can Respir J. doi:10.1155/2008/173904
   Web of Science ®Google Scholar
• Raluy-Callado M, Lambrelli D, MacLachlan S, Khalid JM. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Int J Chron Obstruct Pulmon Dis. 2015;10:925–937. doi:10.2147/COPD.S82064
   PubMed Web of Science ®Google Scholar